News ReleasesRSS
- Apr 19, 2024 Alecensa Approved by FDA as the First Adjuvant Treatment for People with ALK-Positive Early-Stage Non-Small Cell Lung Cancer
- Apr 19, 2024 Chugai In-Licenses RNAi Therapeutic Zilebesiran for Hypertension with High Cardiovascular Risk
- Apr 15, 2024 Positive Phase III Results Showed Vabysmo Improved Vision for the First Time in Japanese in Angioid Streaks
- Apr 09, 2024 Relief Efforts Support for Earthquake Off the Eastern Coast of Taiwan
- Mar 28, 2024 Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan
What's NewRSS
- Mar 28, 2024 Notice of Resolutions of the 113th Annual General Meeting
- Mar 28, 2024 Notice Regarding Year-End Dividend for the Fiscal Year ending December, 2023
- Mar 28, 2024 Finance Report (Jan-Dec2023)
- Feb 27, 2024 Notice of Convocation of the AGM of Shareholders for the Business Term ended December 31, 2023
- Feb 01, 2024 Conference on FY 2023.12 Financial Results